Corporate earnings figures lackluster in first half

With Korea's economy on the brink of recession, domestic pharmaceutical business conditions has been in the doldrums but the management of some pharmaceutical makers rolling out new drugs has seen better performance during the first half of this year, necessitating more active investment in R&D activities and strengthened marketing strategies towards non-flagship drugs.

According to ...